In Reply:
- 1 October 2005
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (28), 7250
- https://doi.org/10.1200/jco.2005.02.1527
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous ThromboembolismJournal of Clinical Oncology, 2005
- Thrombosis and cancer: implications beyond TrousseauJournal of Thrombosis and Haemostasis, 2004
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective AnalysisJournal of Clinical Oncology, 2000